The Good, the Bad and the Ugly: What Retractions Tell Us About Scientific Transparency (2011...

42
The Good, the Bad, and the Ugly: What Retractions Tell Us About Scientific Transparency 2011 CrossRef Annual Member Meeting November 15, 2011 Ivan Oransky, MD Executive Editor, Reuters Health Co-Founder, Retraction Watch http://retractionwatch.com

Transcript of The Good, the Bad and the Ugly: What Retractions Tell Us About Scientific Transparency (2011...

Page 1: The Good, the Bad and the Ugly: What Retractions Tell Us About Scientific Transparency (2011 CrossRef Annual Meeting)

The Good, the Bad, and the Ugly: What Retractions Tell Us About Scientific

Transparency

2011 CrossRef Annual Member MeetingNovember 15, 2011

Ivan Oransky, MDExecutive Editor, Reuters HealthCo-Founder, Retraction Watch

http://retractionwatch.com

Page 2: The Good, the Bad and the Ugly: What Retractions Tell Us About Scientific Transparency (2011 CrossRef Annual Meeting)
Page 3: The Good, the Bad and the Ugly: What Retractions Tell Us About Scientific Transparency (2011 CrossRef Annual Meeting)

Retractions on the Rise

-The Wall Street Journal

Page 4: The Good, the Bad and the Ugly: What Retractions Tell Us About Scientific Transparency (2011 CrossRef Annual Meeting)

Retractions on the Rise

Page 5: The Good, the Bad and the Ugly: What Retractions Tell Us About Scientific Transparency (2011 CrossRef Annual Meeting)

Retractions on the Rise

-Nature

Page 6: The Good, the Bad and the Ugly: What Retractions Tell Us About Scientific Transparency (2011 CrossRef Annual Meeting)

Retractions on the Rise

-Neil Saunders

Page 7: The Good, the Bad and the Ugly: What Retractions Tell Us About Scientific Transparency (2011 CrossRef Annual Meeting)

The Unofficial Record Holder

Page 8: The Good, the Bad and the Ugly: What Retractions Tell Us About Scientific Transparency (2011 CrossRef Annual Meeting)

Which Journals Retract?

-Infection and Immunity 2011

Page 9: The Good, the Bad and the Ugly: What Retractions Tell Us About Scientific Transparency (2011 CrossRef Annual Meeting)

Which Journals Retract?

Page 10: The Good, the Bad and the Ugly: What Retractions Tell Us About Scientific Transparency (2011 CrossRef Annual Meeting)

Why Do Journals Retract?

-Journal of Medical Ethics 2010

Page 11: The Good, the Bad and the Ugly: What Retractions Tell Us About Scientific Transparency (2011 CrossRef Annual Meeting)

Why Do Journals Retract?

• Error is more common than fraud• 73.5% of papers were retracted for error (or an

undisclosed reason) vs 26.6% for fraud• Most common reason for retraction: a scientific

mistake (234 papers; 31.5%)• Fabrication (including data plagiarism) more

common than text plagiarism • Multiple reasons for retraction cited for 67

papers (9.0%), but 134 papers (18.1%) were retracted for ambiguous reasons

-Journal of Medical Ethics 2010

Page 12: The Good, the Bad and the Ugly: What Retractions Tell Us About Scientific Transparency (2011 CrossRef Annual Meeting)

Duplication

Page 13: The Good, the Bad and the Ugly: What Retractions Tell Us About Scientific Transparency (2011 CrossRef Annual Meeting)

Publisher Error

Page 14: The Good, the Bad and the Ugly: What Retractions Tell Us About Scientific Transparency (2011 CrossRef Annual Meeting)

Plagiarism

Page 15: The Good, the Bad and the Ugly: What Retractions Tell Us About Scientific Transparency (2011 CrossRef Annual Meeting)

Legal Reasons

Page 16: The Good, the Bad and the Ugly: What Retractions Tell Us About Scientific Transparency (2011 CrossRef Annual Meeting)

Lack of IRB Approval

Page 17: The Good, the Bad and the Ugly: What Retractions Tell Us About Scientific Transparency (2011 CrossRef Annual Meeting)

Authorship Issues

Page 18: The Good, the Bad and the Ugly: What Retractions Tell Us About Scientific Transparency (2011 CrossRef Annual Meeting)

Fraud: Image Manipulation

Page 19: The Good, the Bad and the Ugly: What Retractions Tell Us About Scientific Transparency (2011 CrossRef Annual Meeting)

Fraud: Faked Data

Page 20: The Good, the Bad and the Ugly: What Retractions Tell Us About Scientific Transparency (2011 CrossRef Annual Meeting)

Not Reproducible

Page 21: The Good, the Bad and the Ugly: What Retractions Tell Us About Scientific Transparency (2011 CrossRef Annual Meeting)

What Happens to Retracted Papers?

-Assn of College & Research Libraries 2011

Page 22: The Good, the Bad and the Ugly: What Retractions Tell Us About Scientific Transparency (2011 CrossRef Annual Meeting)

What Happens to Retracted Papers?

Budd et al, 1999: • Retracted articles received more than 2,000 post-

retraction citations; less than 8% of citations acknowledged the retraction

• Preliminary study of the present data shows that continued citation remains a problem

• Of 391 citations analyzed, only 6% acknowledge the retraction

Page 23: The Good, the Bad and the Ugly: What Retractions Tell Us About Scientific Transparency (2011 CrossRef Annual Meeting)

This is Transparency?

Page 24: The Good, the Bad and the Ugly: What Retractions Tell Us About Scientific Transparency (2011 CrossRef Annual Meeting)

This is Transparency?

Page 25: The Good, the Bad and the Ugly: What Retractions Tell Us About Scientific Transparency (2011 CrossRef Annual Meeting)

This is Transparency?• ‘important irregularities’ Well, if they’re

important irregularities, why don’t you tell us what they are?

• ‘the authors ‘no longer stand by their results’ Are they standing somewhere else in the lab? C’mon, tell us why they can’t stand by the results anymore.

• ‘incorrect data were found to have been included on the study Case Report Forms’ Paging Dr. Kafka.

Page 26: The Good, the Bad and the Ugly: What Retractions Tell Us About Scientific Transparency (2011 CrossRef Annual Meeting)

This is Transparency?• ‘figure withdrawn due to lack of supporting data’

“Someone seems to have made this up.”

• ‘Retraction…is being done for legal reasons based on the advice of counsel’ We’d comment on this, but we’d probably get sued.

• ‘Numerous errors in the text and references… were not discovered until after publication, although neither novel ideas nor data were misappropriated’ As journalism error maven Craig Silverman would say on RegretTheError.com, “Rest is fine.”

Page 27: The Good, the Bad and the Ugly: What Retractions Tell Us About Scientific Transparency (2011 CrossRef Annual Meeting)

This is Transparency?

Page 28: The Good, the Bad and the Ugly: What Retractions Tell Us About Scientific Transparency (2011 CrossRef Annual Meeting)

This is Transparency?In this Letter we made errors in representative image choice, including mislabelling of images or choosing an image from the inappropriate genotype. In all cases, choice of images was completely independent of the data analysis and so none of the conclusions in our original Letter are affected. We apologise for any confusion these errors may have caused.

Page 29: The Good, the Bad and the Ugly: What Retractions Tell Us About Scientific Transparency (2011 CrossRef Annual Meeting)

This is Transparency?In this Letter we made errors in representative image choice, including mislabelling of images or choosing an image from the inappropriate genotype. In all cases, choice of images was completely independent of the data analysis and so none of the conclusions in our original Letter are affected. We apologise for any confusion these errors may have caused.

Figure 1a depicts a Tbr1 staining of the adult mouse cortex for four different genotypes. In the process of choosing representative pictures that reflect the results of our analysis shown in Fig. 1b, cropped images from original pictures were inadvertently mislabelled and used incorrectly. We provide below a corrected version of Fig. 1a with new representative images for the following genotypes: WT and Reln1/1;Efnb32/2. A new high-magnification picture for WT is also shown in the two rightmost panels. Original images for every genotype and additional examples are shown in the Supplementary Information of this Corrigendum.

Page 30: The Good, the Bad and the Ugly: What Retractions Tell Us About Scientific Transparency (2011 CrossRef Annual Meeting)

This is Transparency?In this Letter we made errors in representative image choice, including mislabelling of images or choosing an image from the inappropriate genotype. In all cases, choice of images was completely independent of the data analysis and so none of the conclusions in our original Letter are affected. We apologise for any confusion these errors may have caused.

Figure 1a depicts a Tbr1 staining of the adult mouse cortex for four different genotypes. In the process of choosing representative pictures that reflect the results of our analysis shown in Fig. 1b, cropped images from original pictures were inadvertently mislabelled and used incorrectly. We provide below a corrected version of Fig. 1a with new representative images for the following genotypes: WT and Reln1/1;Efnb32/2. A new high-magnification picture for WT is also shown in the two rightmost panels. Original images for every genotype and additional examples are shown in the Supplementary Information of this Corrigendum.

Figure 1c depicts a Brn1 staining of the E17.5 mouse cortex for five different genotypes. In the process of figure assembly cropped images from original pictures were inadvertently mislabelled and used incorrectly. We provide below a corrected Fig. 1c with a new image for Reln1/1; Efnb3–/–. In the ephrinB3 compound mice (Reln1/2; Efnb32/2) Brn11 cells aberrantly accumulate in the lower layers of the cortex and do not migrate to the upper layers, resembling the Reeler (Reln2/2) phenotype. Original pictures and additional examples are shown in the Supplementary Information of this Corrigendum, where arrows indicate the distribution of Brn11 cells. We have also included results from a new, reproduced experiment recently performed with an additional cohort of animals that shows exactly the same results.

Page 31: The Good, the Bad and the Ugly: What Retractions Tell Us About Scientific Transparency (2011 CrossRef Annual Meeting)

This is Transparency?In this Letter we made errors in representative image choice, including mislabelling of images or choosing an image from the inappropriate genotype. In all cases, choice of images was completely independent of the data analysis and so none of the conclusions in our original Letter are affected. We apologise for any confusion these errors may have caused.

Figure 1a depicts a Tbr1 staining of the adult mouse cortex for four different genotypes. In the process of choosing representative pictures that reflect the results of our analysis shown in Fig. 1b, cropped images from original pictures were inadvertently mislabelled and used incorrectly. We provide below a corrected version of Fig. 1a with new representative images for the following genotypes: WT and Reln1/1;Efnb32/2. A new high-magnification picture for WT is also shown in the two rightmost panels. Original images for every genotype and additional examples are shown in the Supplementary Information of this Corrigendum.

Figure 1c depicts a Brn1 staining of the E17.5 mouse cortex for five different genotypes. In the process of figure assembly cropped images from original pictures were inadvertently mislabelled and used incorrectly. We provide below a corrected Fig. 1c with a new image for Reln1/1; Efnb3–/–. In the ephrinB3 compound mice (Reln1/2; Efnb32/2) Brn11 cells aberrantly accumulate in the lower layers of the cortex and do not migrate to the upper layers, resembling the Reeler (Reln2/2) phenotype. Original pictures and additional examples are shown in the Supplementary Information of this Corrigendum, where arrows indicate the distribution of Brn11 cells. We have also included results from a new, reproduced experiment recently performed with an additional cohort of animals that shows exactly the same results.

In Fig. 1d, the second panel, labelled ‘Reln1/1;Efnb3–/–’ should instead be labelled ‘Reln1/2’. In the Methods summary section ‘Stimulation of neurons’, ‘‘Cortical neurons from E14.5 were grown….’’ should instead read ‘‘Cortical neurons from E15.5 were grown….’’.

(There were mistakes in the supplementary online material, too.)

Page 32: The Good, the Bad and the Ugly: What Retractions Tell Us About Scientific Transparency (2011 CrossRef Annual Meeting)

This is Transparency?

Page 33: The Good, the Bad and the Ugly: What Retractions Tell Us About Scientific Transparency (2011 CrossRef Annual Meeting)

This is Transparency?

Page 34: The Good, the Bad and the Ugly: What Retractions Tell Us About Scientific Transparency (2011 CrossRef Annual Meeting)

This is Transparency?

Page 35: The Good, the Bad and the Ugly: What Retractions Tell Us About Scientific Transparency (2011 CrossRef Annual Meeting)

This is Transparency?“The authors declare that key experiments presented in the majority of these figures were recently reproduced and that the results confirmed the experimental data and the conclusions drawn from them.”

EMBO Journal editor Bernd Pulverer:

“We did not formally investigate this case at the journal and we have not seen this data, as it does not affect the retraction.”

Page 36: The Good, the Bad and the Ugly: What Retractions Tell Us About Scientific Transparency (2011 CrossRef Annual Meeting)

Model Organisms – and Retractions

Page 37: The Good, the Bad and the Ugly: What Retractions Tell Us About Scientific Transparency (2011 CrossRef Annual Meeting)

Model Organisms – and Retractions

Page 38: The Good, the Bad and the Ugly: What Retractions Tell Us About Scientific Transparency (2011 CrossRef Annual Meeting)

Model Retractions

Page 39: The Good, the Bad and the Ugly: What Retractions Tell Us About Scientific Transparency (2011 CrossRef Annual Meeting)

Model Retractions

Page 40: The Good, the Bad and the Ugly: What Retractions Tell Us About Scientific Transparency (2011 CrossRef Annual Meeting)

The Way Forward• Use systems to detect image manipulation and

plagiarism

• Require authors to disclose prior retractions and investigations

• Trust anonymous whistleblowers more

• Demand more of institutions

• Move more quickly to correct and retract

• Make retraction notices clearer - and -

Page 41: The Good, the Bad and the Ugly: What Retractions Tell Us About Scientific Transparency (2011 CrossRef Annual Meeting)

The Way Forward• Make them freely available

Page 42: The Good, the Bad and the Ugly: What Retractions Tell Us About Scientific Transparency (2011 CrossRef Annual Meeting)

Acknowledgements/Contact Info

• Nancy Lapid, Reuters Health• Adam Marcus, Retraction Watch• http://retractionwatch.com• [email protected]• Twitter: @ivanoransky